AllianceBernstein
PJP icon

AllianceBernstein’s Invesco Pharmaceuticals ETF PJP Stock Holding History

AllianceBernstein’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,465
Closed -$151K – 3452
2014
Q2 		$151K Buy
+2,465
New +$143K ﹤0.01% 2897

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
FIG
FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

AllianceBernstein's PJP Position: Q3 2014 in Review

AllianceBernstein sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2014, closing a stake of 2,465 shares — an estimated $151K sold.

AllianceBernstein first reported a position in PJP in Q2 2014 and held it in 1 quarter. The position peaked at $151K in Q2 2014. 90 funds tracked by Wall St. Rank hold PJP as of Q3 2014.

  • AllianceBernstein reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2014 after selling out during the quarter.
  • AllianceBernstein sold 2,465 Invesco Pharmaceuticals ETF shares in Q3 2014, an estimated $151K.
  • AllianceBernstein first reported a position in Invesco Pharmaceuticals ETF in Q2 2014 and held it in 1 quarter.
  • AllianceBernstein's Invesco Pharmaceuticals ETF position peaked at $151K in Q2 2014.
  • 90 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2014.

Based on AllianceBernstein's 13F filing for Q3 2014, filed 13 Nov 2014.